Facebook Live: The Prescription Drug Pricing Pipeline
Who contributes to what you pay at the pharmacy? Why are prescription drugs so expensive in the United States?
drug costs
Hospitals Slashed Use Of Two Heart Drugs After Huge Price Hikes
Even before media reports and a congressional hearing vilified Valeant Pharmaceuticals International for raising prices on a pair of lifesaving heart drugs, Dr. Umesh Khot knew something was very wrong. Khot is a cardiologist at the Cleveland Clinic, which prides itself on outstanding heart care. The health system’s pharmacists had alerted doctors about the skyrocketing cost of the drugs, nitroprusside and isoproterenol. But these two older drugs, frequently used in emergency and intensive care situations, have no direct alternatives.
Whichever Way ‘Repeal and Replace’ Blows, Pharma Is Due For Windfall
The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices, experts say.
Trump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws
With prescription drug prices soaring and President Donald Trump vowing to take action, an old idea is gaining fresh traction: allowing Americans to buy medicines from foreign pharmacies at far lower prices.
Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Before Luke Whitbeck began taking a $300,000-a-year drug, the 2-year-old’s health was inexplicably failing.
A pale boy with enormous eyes, Luke frequently ran high fevers, tired easily and was skinny all over, except his belly stuck out like a bowling ball.
Getting a Handle on Pharmaceutical Costs
Oregon Health Forum explores this timely issue at its breakfast forum on November 2.
High cost specialty drugs have begun outpacing hospital expenditures, and public officials, lawmakers and consumer advocates are hard at work trying to figure out how to get a handle on this growing problem.
Study Says Concerns About Orphan Drug Spending Are Unjustified
Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.
Study: Brand-Name Drugs’ High Copays Soak Medicare Part D Patients
A new study takes a fresh measure of generic drugs’ price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.
The result: 10.5 times more.
FDA Eases Paperwork To Help Some Patients Get Experimental Drugs
The Food and Drug Administration removed an obstacle from of its “compassionate use” policy this month, eliminating some paperwork that physicians must do to obtain experimental drugs for some patients with immediately life-threatening illnesses.
Medicare’s Drug-Pricing Experiment Stirs Opposition
A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centering on whether the plan gives t
Pages
